miR ‐99a‐5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients
Head & Neck · 2023
DOI: 10.1002/hed.27459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2023. Verfasst von Cristiane Pereira Vargas Cousseau und 10 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, MicroRNAs, Head and Neck Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Background
Metastatic lymph node involvement influences therapy decisions and serves as a prognostic indicator in oral squamous cell carcinoma (OSCC). However, many early‐stage patients with clinically negative lymph nodes exhibit no metastasis upon surgical staging. This study aimed to identify differentially expressed miRNAs capable of distinguishing pathologically positive (pN+) from negative (pN0) nodes in OSCC patients without clinical evidence of lymph node metastases (cN0).
Methods
Expression levels of 798 miRNAs were assessed in tumor samples from 10 pN+ and 10 pN0 patients using the Nanostring nCounter platform. Validation was performed in an independent cohort of 15 pN+ and 24 pN0 patients through RT‐qPCR.
Results
Eight miRNAs exhibited differential expression between pN0 and pN+ patients. Notably, hsa‐miR‐99a‐5p demonstrated high sensitivity and specificity in predicting patients at higher risk of positive lymph nodes.
Conclusions
These findings highlight hsa‐miR‐99a‐5p as a potential biomarker for detecting lymph node metastasis in primary OSCC tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
- Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
- Department of Head and Neck Surgery, Barretos Cancer Hospital, Barretos, Brazil.
- Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil.
ORCID-Profile: Cristiane Pereira Vargas Cousseau, Bruna Pereira Sorroche, Renan de Jesus Teixeira, Ana Carolina de Carvalho, Matias Eliseo Melendez, Renato de Castro Capuzzo, Ana Carolina Laus, Luciane Sussuchi da Silva, André Lopes Carvalho, Lidia Maria Rebolho Batista Arantes
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Cousseau, C. P. V., Sorroche, B. P., de Jesus Teixeira, R., de Carvalho, A. C., Melendez, M. E., de Castro Capuzzo, R., Laus, A. C., da Silva, L. S., de Menezes, N. S., Carvalho, A. L., & Arantes, L. M. R. B. (2023). miR ‐99a‐5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients. Head & Neck. https://doi.org/10.1002/hed.27459
Vancouver
Cousseau CPV, Sorroche BP, de Jesus Teixeira R, de Carvalho AC, Melendez ME, de Castro Capuzzo R, et al. miR ‐99a‐5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients. Head & Neck. 2023. doi:10.1002/hed.27459
BibTeX
@article{Cousseau2023,
author = {Cousseau, Cristiane Pereira Vargas and Sorroche, Bruna Pereira and de Jesus Teixeira, Renan and de Carvalho, Ana Carolina and Melendez, Matias Eliseo and de Castro Capuzzo, Renato and Laus, Ana Carolina and da Silva, Luciane Sussuchi and de Menezes, Nei Soares and Carvalho, André Lopes and Arantes, Lidia Maria Rebolho Batista},
title = {miR ‐99a‐5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients},
journal = {Head & Neck},
year = {2023},
doi = {10.1002/hed.27459}
}
EUVIMED